British journal of Cancer |
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP) |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Gastrointestinal Endoscopy |
Low-residue versus clear liquid diet before colonoscopy: a meta-analysis of randomized, controlled trials. |
avr. 16 |
2 ♥ |
Endoscopie/Imagerie |
Inflammatory Bowel Diseases |
2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial |
mai. 17 |
2 ♥ |
MICI |
Gastroenterology |
Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis |
aoû. 15 |
2 ♥ |
MICI |
British journal of Cancer |
Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach |
juin. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma |
Jan. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of Hepatology |
Poor efficacy of nucleic acid testing in identifying occult HBV infection and consequences for safety of blood supply in Italy |
nov. 15 |
2 ♥ |
Foie |
British journal of Cancer |
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations Open |
oct. 17 |
2 ♥ |
Cancers autres |
British journal of Cancer |
Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
Digestive and Liver Disease |
Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience |
avr. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of Hepatology |
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial |
mai. 16 |
2 ♥ |
Foie |
British journal of Cancer |
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Gut |
UK guidelines on the management of variceal haemorrhage in cirrhotic patients |
nov. 15 |
2 ♥ |
Endoscopie/Imagerie, Œsophage/Estomac, Foie |
Cancer Research |
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen. |
sep. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Digestive and Liver Disease |
SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer |
Jan. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Annals of oncology |
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomised trials |
aoû. 17 |
2 ♥ |
Cancer colorectal (CCR) |
Journal of the National Cancer Institute (JNCI) |
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. |
sep. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer |
avr. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of the National Cancer Institute (JNCI) |
The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis |
aoû. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of Hepatology |
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma |
juil. 17 |
2 ♥ |
Foie, Carcinome hépatocellulaire (CHC) |
Inflammatory Bowel Diseases |
Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis |
aoû. 16 |
2 ♥ |
MICI |
Digestive and Liver Disease |
Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC) |
déc. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of Hepatology |
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study |
nov. 15 |
2 ♥ |
Foie |
British journal of Cancer |
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer |
sep. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |